Search

Your search keyword '"Marinello, A"' showing total 496 results

Search Constraints

Start Over You searched for: Author "Marinello, A" Remove constraint Author: "Marinello, A" Topic humans Remove constraint Topic: humans
496 results on '"Marinello, A"'

Search Results

1. Recommendations for accelerating open preprint peer review to improve the culture of science.

2. Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability–High/Mismatch Repair–Deficient Metastatic Colorectal Cancer: KEYNOTE-164

3. DNA Topoisomerase I differentially modulates R-loops across the human genome

4. An international assessment of the adoption of enhanced recovery after surgery (ERAS®) principles across colorectal units in 2019–2020

5. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

6. Balancing Affinity, Selectivity, and Cytotoxicity of Hydrazone-Based G-Quadruplex Ligands for Activation of Interferon β Genes in Cancer Cells

7. Pembrolizumab for myelodysplastic syndromes after failure of hypomethylating agents in the phase 1b KEYNOTE-013 study

8. Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNOTE-204): an interim analysis of a multicentre, randomised, open-label, phase 3 study

9. Development of a novel nomogram-based online tool to predict axillary status after neoadjuvant chemotherapy in cN+ breast cancer: A multicentre study on 1,950 patients

10. A systematic review of breast milk microbiota composition and the evidence for transfer to and colonisation of the infant gut

12. Assessing quality of life in Behçet's disease: a systematic review

13. Impact of perioperative transfusions and sepsis on long-term oncologic outcomes after curative colon cancer resection. A retrospective analysis of a prospective database

14. The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNET

15. Ligands stimulating antitumour immunity as the next G-quadruplex challenge

16. Clinical predictors of cardiac toxicity in HER2-positive early breast cancer patients treated with adjuvant s.c. versus i.v. trastuzumab

17. Exploring patient's experience and unmet needs on pregnancy and family planning in rare and complex connective tissue diseases: a narrative medicine approach

18. Outcomes Following Taxation of Sugar-Sweetened Beverages: A Systematic Review and Meta-analysis

19. Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic

20. Elective Cancer Surgery in COVID-19-Free Surgical Pathways during the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study

21. Telemedicine-assisted care of an older patient with COVID-19 and dementia: bridging the gap between hospital and home

22. Pembrolizumab plus pomalidomide and dexamethasone for relapsed or refractory multiple myeloma (KEYNOTE-183): subgroup analysis in Japanese patients

23. DElayed COloRectal cancer care during COVID-19 Pandemic (DECOR-19): Global perspective from an international survey

24. Polymorphisms of Pro-Inflammatory IL-6 and IL-1β Cytokines in Ascending Aortic Aneurysms as Genetic Modifiers and Predictive and Prognostic Biomarkers

25. Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

26. Delaying surgery for patients with a previous SARS-CoV-2 infection

27. Virological response and retention in care according to time of starting ART in Italy: data from the Icona Foundation Study cohort

28. DNA damage and genome instability by G-quadruplex ligands are mediated by R loops in human cancer cells

29. Perfluorobutane sulfonate exposure disrupted human placental cytotrophoblast cell proliferation and invasion involving in dysregulating preeclampsia related genes

30. The day‐to‐day experiences of caring for children with Osteogenesis Imperfecta: A qualitative descriptive study

31. Effects of developmental exposure to FireMaster® 550 (FM 550) on microglia density, reactivity and morphology in a prosocial animal model

32. Topoisomerase I poison-triggered immune gene activation is markedly reduced in human small-cell lung cancers by impairment of the cGAS/STING pathway

33. Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study

34. Steindler Flexorplasty: A Description of Current Technique and Case Series

35. The association of subcortical brain injury and abusive head trauma

36. Hyperglycemia, Reduced Hematopoietic Stem Cells, and Outcome of COVID-19

37. Italian guidelines in diagnosis and treatment of alopecia areata

38. Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort

39. Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort

40. KEYNOTE-013 4-year follow-up of pembrolizumab in classical Hodgkin lymphoma after brentuximab vedotin failure

41. Laparoscopic Hartmann's reversal: a step-by-step video demonstration - a video vignette

42. Radiation-induced macrophage senescence impairs resolution programs and drives cardiovascular inflammation

43. Endocrine disrupting chemicals (EDCs) and placental function: Impact on fetal brain development

44. Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study

45. Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability–High/Mismatch Repair–Deficient Metastatic Colorectal Cancer: KEYNOTE-164

46. Antibody Therapy for the Control of Viral Diseases: An Update

47. Patient-Centered Risk Assessment in Implant Treatment Planning

48. An analysis of physicians' diagnostic reasoning regarding pediatric abusive head trauma

49. Clinical outcomes of relapsed and refractory Hodgkin lymphoma patients after contemporary first-line treatment: a German Hodgkin Study Group analysis

50. Uncommon single and compound EGFR mutations: clinical outcomes of a heterogeneous subgroup of NSCLC

Catalog

Books, media, physical & digital resources